NCT04022980 2025-12-30
Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma
Wake Forest University Health Sciences
Phase 1 Completed
Clinical Trials
16 trialsNCT01295944 2025-08-05
Carboplatin and Bevacizumab for Recurrent Ependymoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01817751 2024-07-17
Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma
Virginia Commonwealth University
Phase 2 Completed
NCT00928226 2024-01-30
Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
Stanford University
Phase NA Completed
NCT02313272 2023-10-23
Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT04475029 2023-09-13
METAMORF
University of Aarhus
Phase NA Completed
NCT01534104 2023-06-09
MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT05531695 2022-09-08
ESIBAC
Hull University Teaching Hospitals NHS Trust
Phase NA Completed
NCT01120639 2021-08-06
Tx-Treatment
Stanford University
Phase 1/2 Completed
NCT01969370 2017-05-03
NCGENES
University of North Carolina, Chapel Hill
Phase NA Completed
NCT02165163 2015-05-22
Virtual Reality-Based Exercise in Cancer Patients
University of Arizona
Phase NA Completed
NCT00004437 2015-03-25
Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00004832 2015-03-25
Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
FDA Office of Orphan Products Development
Phase NA Completed
NCT00762255 2013-07-25
A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT00185666 2010-07-14
Cyberknife Precision Radiation Delivery System for Tumors of the Spine
Stanford University
Phase 1/2 Completed
NCT00251797 2010-01-07
A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors
University of New Mexico
Phase 1 Completed